官方服务：
资源简介：
This is the main DrugSimDB file containing drug-pair information with significant combined similarity measures.
应用场景：
创建时间：
2020-03-06
相关数据集
Results of the GUILDify v2.0 web server analysis.
Sheet (a) summarizes the overlap between the top-scoring proteins associated with the drugs and the top-scoring proteins associated with SARS-CoV-2 infection sets. Sheet (b) contains figures that illu
NIAID Data Ecosystem80
Additional file 3 of QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
Spreadsheet file with the full list of significant positive connections from QUADrATiC for the HDAC signature used to validate the software. (XLSX 84.0 kb)
NIAID Data Ecosystem40
Binding Affinity.
Alzheimer’s disease (AD) is the most dominant and prevalent form of dementia. The therapeutic agents for AD are not sufficient. Drug repurposing (i.e., also called drug repositioning or therapeutic sw
Figshare2025-12-17 更新20
DataSheet2_Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease.csv
The COVID-19 pandemic prompted several drug repositioning initiatives with the aim to rapidly deliver pharmacological candidates able to reduce SARS-CoV-2 dissemination and mortality. A major issue sh
NIAID Data Ecosystem60
Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters. Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters
COVID-19 is the third outbreak of zoonotic coronavirus (CoV) of the century after the epidemic Severe acute respiratory syndrome CoV (SARS-CoV) in 2003 and Middle East respiratory syndrome CoV (MERS-C
NIAID Data Ecosystem40
